Literature DB >> 29994056

A Hierarchical Bayesian Model for Personalized Survival Predictions.

Alexis Bellot, Mihaela van der Schaar.   

Abstract

We study the problem of personalizing survival estimates of patients in heterogeneous populations for clinical decision support. The desiderata are to improve predictions by making them personalized to the patient-at-hand, to better understand diseases and their risk factors, and to provide interpretable model outputs to clinicians. To enable accurate survival prognosis in heterogeneous populations we propose a novel probabilistic survival model which flexibly captures individual traits through a hierarchical latent variable formulation. Survival paths are estimated by jointly sampling the location and shape of the individual survival distribution resulting in patient-specific curves with quantifiable uncertainty estimates. An understanding of model predictions is paramount in medical practice where decisions have major social consequences. We develop a personalized interpreter that can be used to test the effect of covariates on each individual patient, in contrast to traditional methods that focus on population average effects. We extensively validated the proposed approach in various clinical settings, with a special focus on cardiovascular disease.

Entities:  

Mesh:

Year:  2018        PMID: 29994056     DOI: 10.1109/JBHI.2018.2832599

Source DB:  PubMed          Journal:  IEEE J Biomed Health Inform        ISSN: 2168-2194            Impact factor:   5.772


  2 in total

1.  CD-Surv: a contrastive-based model for dynamic survival analysis.

Authors:  Caogen Hong; Jinbiao Chen; Fan Yi; Yuzhe Hao; Fanwen Meng; Zhanghuiya Dong; Hui Lin; Zhengxing Huang
Journal:  Health Inf Sci Syst       Date:  2022-04-12

Review 2.  State-of-the-Art Machine Learning Techniques Aiming to Improve Patient Outcomes Pertaining to the Cardiovascular System.

Authors:  Rahul Kumar Sevakula; Wan-Tai M Au-Yeung; Jagmeet P Singh; E Kevin Heist; Eric M Isselbacher; Antonis A Armoundas
Journal:  J Am Heart Assoc       Date:  2020-02-13       Impact factor: 5.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.